GlassScriptPhysician profile
Kevin Alan Slaughter
NPI 1245762251
$1,370.24
in general payments reported to CMS, 2019-2025
11 companies · $761 in 2025
The $761 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $92.56 · 2023: $223 · 2024: $293 · 2025: $761.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,277.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $576.50 | 2023-2025 | Novosorb Btm |
| Avita Medical Americas, LLC | $305.42 | 2025 | Recell, Permeaderm, Cohealyx |
| Baxter Healthcare | $139.37 | 2024 | Artiss |
| Kls-Martin L.P. | $77.72 | 2023 | |
| Urgo Medical North America, LLC | $72.14 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Access Pro Medical, LLC | $22.89 | 2023 | Matriderm |
| Tela Bio, INC. | $22.71 | 2024 | Ovitex 2s |
| Merck Sharp & Dohme LLC | $21.61 | 2025 | Zerbaxa |
| Smith+Nephew, INC. | $16.74 | 2024 | Versajet, Acticoat 4" X 4", Collagenase Santyl |
| Prytime Medical Devices, INC. | $13.38 | 2024 | Er-Reboa Plus |
| Intuitive Surgical, INC. | $9.20 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Slaughter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.